Baseline and Dynamic Changes in Hemoglobin Levels Predict Treatment Response and Prognosis in Metastatic Renal Cell Carcinoma: A Multicenter Retrospective Study-Reference-Cited by-同舟云学术

Baseline and Dynamic Changes in Hemoglobin Levels Predict Treatment Response and Prognosis in Metastatic Renal Cell Carcinoma: A Multicenter Retrospective Study

Published:2023-08 Issue:4 Volume:21 Page:e242-e251
ISSN:1558-7673
Container-title:Clinical Genitourinary Cancer
language:en
Short-container-title:Clinical Genitourinary Cancer

Author:

Yang Yu-Hsuen^ORCID,Ansel Sonam,Meerveld-Eggink Aafke,Jackson-Spence Francesca^ORCID,Rallis Kathrine,Brian Paul,Choy Julia,Sng Christopher,Adeniran Philip,Amin Jubel,Galope Sarah,Anderson Naomi,Bex Axel,Powles Thomas,Venugopal Balaji,Szabados Bernadett^ORCID

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference38 articles.

1. Outcomes of patients with metastatic renal cell carcinoma that do not meet eligibility criteria for clinical trials;Heng;Ann Oncol,2014

2. Prognostic indicators for renal cell carcinoma: a multivariate analysis of 643 patients using the revised 1997 TNM staging criteria;Tsui;J Urol,2000

3. Pathological stage T3a significantly increases disease recurrence across all tumor sizes in renal cell carcinoma;Chevinsky;J Urol,2015

4. Renal cell carcinoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up†;Escudier;Ann Oncol,2019

5. Sunitinib for the first-line treatment of advanced and/or metastatic renal cell carcinoma. Technology appraisal guidance [TA169] NICE. Available at: https://www.nice.org.uk/guidance/ta169.Accessed: April 1, 2022.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Importance of Hypoxia-Related to Hemoglobin Concentration in Breast Cancer;Cell Biochemistry and Biophysics;2024-07-03

2. External validation of a red cell-based blood prognostic score in patients with metastatic renal cell carcinoma treated with first-line immunotherapy combinations;Clinical & Experimental Metastasis;2024-02-16

3. External Validation of a Red Cell-based Blood Prognostic Score in Patients With Metastatic Renal Cell Carcinoma Treated With First- Line Immunotherapy Combinations;2023-10-10